Upload Avatar (500 x 500)
Xu Yun
xuyun20042001@aliyun.com
Chinese, English, German
Jiangsu
Nanjing University
Medical School
  • Studied at Heidelberg University, Germany
  • Studied at Johns Hopkins University, USA
  • Published over 400 papers
  • 166 SCI papers as corresponding author
  • Total impact factor: 542.145
  • H-index: 36
  • 7 patents and software copyrights
  • Authored and co-authored 10 books
  • Vice President of Nanjing University Brain Science Institute
  • Director of Jiangsu Provincial Cerebrovascular Disease Treatment Center
  • Current - Nanjing University Gulou Hospital - Director of Neurology
  • Current - Nanjing University Brain Science Institute - Vice President
  • Current - Jiangsu Provincial Cerebrovascular Disease Treatment Center - Director
  • Jiangsu Provincial Science and Technology Award First Prize (2020): Precision Diagnosis and Treatment of Ischemic Stroke
  • Jiangsu Medical Science and Technology Award First Prize (2020): Immune Inflammation Mechanism and Clinical Translation of Ischemic Brain Injury
  • Jiangsu Provincial Health Commission New Technology Introduction Award First Prize (2020): Early Diagnosis of Cerebral Small Vessel Disease with Multimodal MRI
  • Jiangsu Provincial Science and Technology Award Second Prize (2015, 2011): Translational Medical Research on Brain Disease-Related Brain Injury
  • Chinese Medical Award Third Prize (2011): Clinical Translation of Molecular and Imaging Biomarkers for Early Diagnosis of High AD Risk MCI
Basic and Clinical Research on Cerebrovascular Diseases
Basic and Clinical Research on Dementia
Basic and Clinical Translational Research on Stem Cells
  • Double-negative T cells remarkably promote neuroinflammation after ischemic stroke, Meng H, Zhao H, Cao X, Hao J, Zhang H, Liu Y, Zhu M, Fan L, Weng L, Qian L, Wang X, Xu Y*, 2019
  • HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer’s disease, Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y*, 2017
  • Microglial lnc-U90926 facilitates neutrophil infiltration in ischemic stroke via MDH2/CXCL2 axis, Chen J, Jin J, Zhang X, Yu H, Zhu X, Yu L, Chen Y, Liu P, Dong X, Cao X, Gu Y, Bao X, Xia S, Xu Y*, 2021
  • HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by down-regulating the AIM2 inflammasome, Zhang M, Zhao Q, Xia M, Chen J, Chen Y, Cao X, Yuan Z, Wang X, Xu Y*, 2020
  • FasL-PDPK1 pathway promotes the cytotoxicity of CD8+ T cells during ischemic stroke, Fan L, Zhang C, Zhu L, Chen J, Zhang Z, Liu P, Cao X, Meng H, Xu Y*, 2020
  • miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease, Tao W, Yu L, Shu S, Liu Y, Zhuang Z, Xu S, Bao X, Gu Y, Cai F, Song W, Xu Y*, Zhu X*, 2021
  • Targeting connexin 43 provides anti-inflammatory effects after intracerebral hemorrhage injury by regulating YAP signaling, Yu H, Cao X, Li W, Liu P, Zhao Y, Song L, Chen J, Chen B, Yu W*, Xu Y*, 2020
  • Disrupted functional and structural connectivity within default mode network contribute to WMH-related cognitive impairment, Chen X, Huang Li, Ye Q, Yang D, Qin R, Luo C, Li M, Zhang B, Xu Y*, 2019
  • Progression of White Matter Hyperintensities Contributes to Lacunar Infarction, Xu X, Gao Y, Liu R, Qian L, Chen Y, Wang X, Xu Y*, 2018
  • Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage, Ji B, Zhou F, Han L, Yang J, Fan H, Li Shan, Li J, Zhang X, Wang X, Chen X, Xu Y*, 2017
Cerebrovascular Diseases Stroke Ischemia Neuroinflammation Brain Injury Clinical Research Basic Research Translational Research Neurology Therapeutics Dementia Alzheimer'S Disease Cognitive Impairment Neurodegeneration Memory Loss Stem Cells Regenerative Medicine Cell Therapy Neuroregeneration Clinical Trials Cell Biology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.